ABPI outlines terms for pharmaceutical pricing regulation scheme replacement
The Association of the British Pharmaceutical Industry has outlined terms with the Government for the Voluntary Scheme for Branded Medicines Pricing and Access (the “Voluntary Scheme”), to help the NHS with getting the best value and most effective medicines into use quickly.
The Voluntary Scheme is expected to come into effect from January 2019 and will replace the current Pharmaceutical Pricing Regulation Scheme (PPRS), which expires on 31 December 2018. The Voluntary Scheme will hopefully ensure new medicines are assessed by the National Institute for Health and Care Excellence a lot faster than currently in terms of both clinical and cost effectiveness, as well as getting clinicians and the NHS ready to use such new medicines as soon as possible.